Skip to content

Clinical trials

Phase 2 Hepatitis, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Chronic Phase: Phase 2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20091
20101
20121
20132
20152
20161
20181
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AusperBio Therapeutics Inc.2
Bristol-Myers Squibb2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
AbbVie1
F-star Therapeutics, Inc.1
Gilead Sciences1
Hospital Sao Rafael1
Novartis Pharmaceuticals1
Pfizer1
Veloxis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Chronic14
Liver Diseases6
Hepatitis5
Hepatitis C5
Virus Diseases5
Hepatitis, Viral, Human4
Digestive System Diseases3
Hepatitis B3
Hepatitis C, Chronic3
Blood-Borne Infections2

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.